Evaluation of pharmacological efficacy and safety of hydroxyurea in sickle cell disease: Study of a pediatric cohort from Chhattisgarh, India.
Pediatr Hematol Oncol
; 40(4): 395-406, 2023 May.
Article
in En
| MEDLINE
| ID: mdl-36226857
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Beta-Thalassemia
/
Drug-Related Side Effects and Adverse Reactions
/
Anemia, Sickle Cell
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Child
/
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Pediatr Hematol Oncol
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
/
PEDIATRIA
Year:
2023
Type:
Article
Affiliation country:
India